srf617
Generic: Perenostobart
srf617: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Surface Oncology, Inc. (SURF) | Phase 1 |
Get deeper analysis on srf617
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis